- About
-
Projects
-
Column 1
- Advancing Regulatory Science
- Animal Health & Veterinary Medicine
- Expanded Access
- FDA Patient Listening Sessions
-
Column 2
- Food & Nutrition
- Improving Access to FDA Information
- Research
- Substance Use Disorders
-
Column 1
- News and Events
- Expanded Access eRequest
Announcements
(February 6, 2026) The Reagan-Udall Foundation for the FDA (Foundation) has appointed Adrian F. Hernandez, MD, MHS, as Chair of its Board of Directors. Dr. Hernandez, who has served on the Board since 2019, is a cardiologist and the Vice Dean for…
The Reagan-Udall Foundation for the FDA will honor the Produce Safety Alliance, Critical Path Institute, and Loren A. Eng with its Innovations in Regulatory Science & Policy Awards on December 9, 2025.
The Reagan-Udall Foundation for the FDA (the Foundation) seeks nominations for its annual Innovations in Regulatory Science & Policy Awards.
Coverage
Ketamine Statistics: Ketamine is a dissociative anesthetic primarily used in surgical settings for its rapid onset and pain relief properties.
The Reagan-Udall Foundation for the FDA will host a hybrid public meeting on Advancing Drug Development by Reducing Reliance on Animal Testing on 26 February.
The guidance includes new information to help providers, patients, and others learn about drug companies’ expanded access policies with a link to the FDA Reagan-Udall Foundation’s Expanded Access Navigator website. The website includes extensive…